- Report
- July 2023
- 253 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Report
- June 2023
- 250 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- February 2022
- 211 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- October 2023
- 110 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2023
- 119 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2023
- 119 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2021
- 102 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2018
Global
From €4295EUR$4,500USD£3,598GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 118 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 114 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2023
- 140 Pages
Global
From €3435EUR$3,599USD£2,878GBP
- Report
- May 2023
- 140 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- February 2024
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 172 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 130 Pages
Europe
From €3818EUR$4,000USD£3,199GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more